𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Zoledronic acid in treatment of bone lesions by Langerhans cell histiocytosis

✍ Scribed by Liliana Montella; Carmela Merola; Geraldina Merola; Luigi Petillo; Giovannella Palmieri


Publisher
Springer
Year
2008
Tongue
English
Weight
185 KB
Volume
27
Category
Article
ISSN
0914-8779

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Etoposide in the treatment of six childr
✍ Viana, Marcos Borato ;Oliveira, Benigna Maria ;Silva, Celia Maria ;Leite, Virgin πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 548 KB

Six children received etoposide as the single agent for treatment of Langerhans cell histiocytosis (LCH; histiocytosis X). Five were less than 2 years old at diagnosis. All had multiorgan involvement; one had liver and pulmonary dysfunction. Two infants also had clinical signs of immune deficiency.

β€œEtoposide in the treatment of six child
✍ Whitlock, James A. πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 89 KB

Viana et al. [I] described their experience with etoposide (VP-16) as initial therapy in the management of patients with Langerhans cell histiocytosis (LCH). However, caution should be used in advocating the use of an epipodophyllotoxin as the "drug of choice" for the treatment of this disorder. Alt

T-Lymphocytes bearing the Ξ³Ξ΄ T-cell rece
✍ Alaibac, Mauro ;Chu, Anthony C. πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 611 KB

## Abstract The aim of this study was to investigate the regional importance of Ξ³Ξ΄ T cells in cutaneous lesions of Langerhans' cell histiocytosis. Six cases of Langerhans' cell histiocytosis were investigated by immunohistochemical techniques (alkaline phosphatase‐antialkaline phosphatase complex a